Microstructured titanium regulates interleukin production by osteoblasts, an effect modulated by exogenous BMP-2

Acta Biomaterialia

Volumn 9, Issue 3, 2013, Pages 5821-5829

  Hyzy, S L ^a   Olivares Navarrete, R ^a   Hutton, D L ^a   Tan, C ^a   Boyan, B D ^a   Schwartz, Z ^a,b  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Bone morphogenetic protein; Inflammation; Microstructure; Osteoblast; Titanium

Indexed keywords

BONE; CELL SIGNALING; MICROSTRUCTURE; OSTEOBLASTS; RECOMBINANT PROTEINS; SIGNALING; TISSUE CULTURE;

ANTI-INFLAMMATORIES; BONE MORPHOGENETIC PROTEIN-2; BONE MORPHOGENETIC PROTEINS; HUMAN BONE MORPHOGENETIC PROTEIN; HYDROPHILICS; IMPLANT SURFACE; IN-VITRO; OSSEOINTEGRATION; OSTEOBLAST DIFFERENTIATION; TITANIA;

TITANIUM;

7 OXOZEAENOL; ALKALINE PHOSPHATASE; CYTOKINE; DORSOMORPHIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; N (2 METHYLAMINOETHYL) 5 ISOQUINOLINESULFONAMIDE; POLYSTYRENE; PROTEIN INHIBITOR; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; TITANIUM; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; BONE REGENERATION; CELL COUNT; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROPHILICITY; IMPLANT; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 84873163682     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.10.030     Document Type: Article

References (68)

1. J. Sela, U.M. Gross, D. Kohavi, J. Shani, D.D. Dean, and B.D. Boyan Primary mineralization at the surfaces of implants Crit Rev Oral Biol Med 11 2000 423 436 (Pubitemid 32003255)
2. B.D. Boyan, S. Lossdorfer, L. Wang, G. Zhao, C.H. Lohmann, and D.L. Cochran Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies Eur Cell Mater 6 2003 22 27 (Pubitemid 38851419)
3. B.F. Boyce, and L. Xing Functions of RANKL/RANK/OPG in bone modeling and remodeling Arch Biochem Biophys 473 2008 139 146
4. Z. Schwartz, R. Olivares-Navarrete, M. Wieland, D.L. Cochran, and B.D. Boyan Mechanisms regulating increased production of osteoprotegerin by osteoblasts cultured on microstructured titanium surfaces Biomaterials 30 2009 3390 3396
5. P.M. Mountziaris, and A.G. Mikos Modulation of the inflammatory response for enhanced bone tissue regeneration Tissue Eng B Rev 14 2008 179 186 (Pubitemid 351839215)
6. P. Kolar, K. Schmidt-Bleek, H. Schell, T. Gaber, D. Toben, and G. Schmidmaier The early fracture hematoma and its potential role in fracture healing Tissue Eng B Rev 16 2010 427 434
7. T. Kon, T.J. Cho, T. Aizawa, M. Yamazaki, N. Nooh, and D. Graves Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing J Bone Miner Res 16 2001 1004 1014 (Pubitemid 32467144)
8. T.J. Cho, L.C. Gerstenfeld, and T.A. Einhorn Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing J Bone Miner Res 17 2002 513 520 (Pubitemid 34171766)
9. C.H. Rundle, H. Wang, H. Yu, R.B. Chadwick, E.I. Davis, and J.E. Wergedal Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair Bone 38 2006 521 529
10. M.L. Isidro, and B. Ruano Bone disease in diabetes Curr Diabetes Rev 6 2010 144 155
11. J.M. Duckers, B.A. Evans, W.D. Fraser, M.D. Stone, C.E. Bolton, and D.J. Shale Low bone mineral density in men with chronic obstructive pulmonary disease Respir Res 12 2011 101
12. P.D. Miller Diagnosis and treatment of osteoporosis in chronic renal disease Semin Nephrol 29 2009 144 155
13. J. Collier Bone disorders in chronic liver disease Hepatology 46 2007 1271 1278 (Pubitemid 350144791)
14. N. Donos, M. Retzepi, I. Wall, S. Hamlet, and S. Ivanovski In vivo gene expression profile of guided bone regeneration associated with a microrough titanium surface Clin Oral Implants Res 22 2011 390 398
15. S. Ivanovski, S. Hamlet, G.E. Salvi, G. Huynh-Ba, D.D. Bosshardt, and N.P. Lang Transcriptional profiling of osseointegration in humans Clin Oral Implants Res 22 2011 373 381
16. H. Terheyden, N.P. Lang, S. Bierbaum, and B. Stadlinger Osseointegration-communication of cells Clin Oral Implants Res 23 2011 1127 1135
17. P.M. Kou, Z. Schwartz, B.D. Boyan, and J.E. Babensee Dendritic cell responses to surface properties of clinical titanium surfaces Acta Biomater 7 2011 1354 1363
18. T. Kishimoto The biology of interleukin-6 Blood 74 1989 1 10 (Pubitemid 19187402)
19. G.D. Roodman Regulation of osteoclast differentiation Ann N Y Acad Sci 1068 2006 100 109 (Pubitemid 43824141)
20. F. Shen, M.J. Ruddy, P. Plamondon, and S.L. Gaffen Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells J Leukoc Biol 77 2005 388 399 (Pubitemid 40289569)
21. R. Sabat, G. Grutz, K. Warszawska, S. Kirsch, E. Witte, and K. Wolk Biology of interleukin-10 Cytokine Growth Factor Rev 21 2010 331 344
22. S.M. Opal, and V.A. DePalo Anti-inflammatory cytokines Chest 117 2000 1162 1172 (Pubitemid 30228378)
23. E. Cenni, D. Granchi, G. Ciapetti, L. Savarino, A. Corradini, and M. Vancini Gene expression of bone-associated cytokines in MG63 osteoblast-like cells incubated with acrylic bone cement extracts in minimum essential medium J Biomater Sci Polym Ed 13 2002 1283 1294 (Pubitemid 36124100)
24. E. Cenni, D. Granchi, G. Ciapetti, S. Stea, L. Savarino, and A. Corradini Interleukin-6 expression by osteoblast-like MG63 cells challenged with four acrylic bone cements J Biomater Sci Polym Ed 12 2001 243 253 (Pubitemid 32515009)
25. M. Tschon, M. Fini, G. Giavaresi, P. Torricelli, L. Rimondini, and L. Ambrosio In vitro and in vivo behaviour of biodegradable and injectable PLA/PGA copolymers related to different matrices Int J Artif Organs 30 2007 352 362 (Pubitemid 46938860)
26. M. Wan, and X. Cao BMP signaling in skeletal development Biochem Biophys Res Commun 328 2005 651 657 (Pubitemid 40208302)
27. F. Thorey, H. Menzel, C. Lorenz, G. Gross, A. Hoffmann, and H. Windhagen Osseointegration by bone morphogenetic protein-2 and transforming growth factor beta2 coated titanium implants in femora of New Zealand white rabbits Indian J Orthop 45 2011 57 62
28. J.F. Decker, J. Lee, C.A. Cortella, G. Polimeni, M.D. Rohrer, and J.M. Wozney Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs J Periodontol 81 2010 1839 1849
29. G.B. Bishop, and T.A. Einhorn Current and future clinical applications of bone morphogenetic proteins in orthopaedic trauma surgery Int Orthop 31 2007 721 727 (Pubitemid 350160314)
30. K.R. Garrison, S. Donell, J. Ryder, I. Shemilt, M. Mugford, and I. Harvey Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review Health Technol Assess 11 iii-iv 2007 1 150
31. J.K. Burkus, J.D. Dorchak, and D.L. Sanders Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2 Spine (Phila Pa 1976) 28 2003 372 377 (Pubitemid 36232619)
32. S.D. Glassman, J.R. Dimar, L.Y. Carreon, M.J. Campbell, R.M. Puno, and J.R. Johnson Initial fusion rates with recombinant human bone morphogenetic protein-2/compression resistant matrix and a hydroxyapatite and tricalcium phosphate/collagen carrier in posterolateral spinal fusion Spine (Phila Pa 1976) 30 2005 1694 1698 (Pubitemid 41099480)
33. S.D. Boden, J. Kang, H. Sandhu, and J.G. Heller Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial: 2002 Volvo Award in clinical studies Spine (Phila Pa 1976) 27 2002 2662 2673 (Pubitemid 35425320)
34. K.N. Leknes, J. Yang, M. Qahash, G. Polimeni, C. Susin, and U.M. Wikesjo Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: radiographic observations Clin Oral Implants Res 19 2008 1027 1033
35. M.E. Oetgen, and B.S. Richards Complications associated with the use of bone morphogenetic protein in pediatric patients J Pediatr Orthop 30 2010 192 198
36. T. Smoljanovic, I. Bojanic, and D. Delimar Adverse effects of posterior lumbar interbody fusion using rhBMP-2 Eur Spine J 18 2009 920 923 [author reply 4]
37. K.B. Lee, S.S. Murray, C.E. Taghavi, K.J. Song, E.J. Brochmann, and J.S. Johnson Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation Spine J 11 2011 568 576
38. K.B. Lee, C.E. Taghavi, K.J. Song, C. Sintuu, J.H. Yoo, and G. Keorochana Inflammatory characteristics of rhBMP-2 in vitro and in an in vivo rodent model Spine (Phila Pa 1976) 36 2011 149 154
39. G. Zhao, A.L. Raines, M. Wieland, Z. Schwartz, and B.D. Boyan Requirement for both micron- and submicron scale structure for synergistic responses of osteoblasts to substrate surface energy and topography Biomaterials 28 2007 2821 2829 (Pubitemid 46482664)
40. G. Zhao, Z. Schwartz, M. Wieland, F. Rupp, J. Geis-Gerstorfer, and D.L. Cochran High surface energy enhances cell response to titanium substrate microstructure J Biomed Mater Res A 74 2005 49 58 (Pubitemid 41099250)
41. M. Bachle, and R.J. Kohal A systematic review of the influence of different titanium surfaces on proliferation, differentiation and protein synthesis of osteoblast-like MG63 cells Clin Oral Implants Res 15 2004 683 692 (Pubitemid 40115756)
42. J.Y. Martin, Z. Schwartz, T.W. Hummert, D.M. Schraub, J. Simpson, and J. Lankford Jr. Effect of titanium surface roughness on proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63) J Biomed Mater Res 29 1995 389 401
43. M.K. Choo, N. Kawasaki, P. Singhirunnusorn, K. Koizumi, S. Sato, and S. Akira Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade Mol Cancer Ther 5 2006 2970 2976 (Pubitemid 46092038)
44. J. Ninomiya-Tsuji, T. Kajino, K. Ono, T. Ohtomo, M. Matsumoto, and M. Shiina A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase J Biol Chem 278 2003 18485 18490 (Pubitemid 36799472)
45. P.B. Yu, C.C. Hong, C. Sachidanandan, J.L. Babitt, D.Y. Deng, and S.A. Hoyng Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism Nat Chem Biol 4 2008 33 41 (Pubitemid 350273653)
46. J. Hao, M.A. Daleo, C.K. Murphy, P.B. Yu, J.N. Ho, and J. Hu Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells PLoS One 3 2008 e2904
47. H. Hidaka, M. Inagaki, S. Kawamoto, and Y. Sasaki Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C Biochemistry 23 1984 5036 5041 (Pubitemid 15206436)
48. N. Niisato, Y. Ito, and Y. Marunaka Effects of PKA inhibitors, H-compounds, on epithelial Na+ channels via PKA-independent mechanisms Life Sci 65 1999 PL109 PL114
49. J. Ding, O. Ghali, P. Lencel, O. Broux, C. Chauveau, and J.C. Devedjian TNF-alpha and IL-1beta inhibit RUNX2 and collagen expression but increase alkaline phosphatase activity and mineralization in human mesenchymal stem cells Life Sci 84 2009 499 504
50. J. Lange, A. Sapozhnikova, C. Lu, D. Hu, X. Li, and T. Miclau III Action of IL-1beta during fracture healing J Orthop Res 28 2010 778 784
51. T. Miclau, C. Lu, Z. Thompson, P. Choi, C. Puttlitz, and R. Marcucio Effects of delayed stabilization on fracture healing J Orthop Res 25 2007 1552 1558 (Pubitemid 350293802)
52. F. Blanchard, L. Duplomb, M. Baud'huin, and B. Brounais The dual role of IL-6-type cytokines on bone remodeling and bone tumors Cytokine Growth Factor Rev 20 2009 19 28
53. W.B. Ershler, and E.T. Keller Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty Annu Rev Med 51 2000 245 270 (Pubitemid 30216036)
54. S. Stea, M. Visentin, D. Granchi, G. Ciapetti, M.E. Donati, and A. Sudanese Cytokines and osteolysis around total hip prostheses Cytokine 12 2000 1575 1579
55. Y.T. Konttinen, J.W. Xu, E. Waris, T.F. Li, E. Gomez-Barrena, and L. Nordsletten Interleukin-6 in aseptic loosening of total hip replacement prostheses Clin Exp Rheumatol 20 2002 485 490 (Pubitemid 34846622)
56. A.B. Petkovic, S.M. Matic, N.V. Stamatovic, D.V. Vojvodic, T.M. Todorovic, and Z.R. Lazic Proinflammatory cytokines (IL-1beta and TNF-alpha) and chemokines (IL-8 and MIP-1alpha) as markers of peri-implant tissue condition Int J Oral Maxillofac Surg 39 2010 478 485
57. J. Akech, J.J. Wixted, K. Bedard, M. van der Deen, S. Hussain, and T.A. Guise Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions Oncogene 29 2010 811 821
58. E. Lubberts, L. van den Bersselaar, B. Oppers-Walgreen, P. Schwarzenberger, C.J. Coenen-de Roo, and J.K. Kolls IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance J Immunol 170 2003 2655 2662 (Pubitemid 36245658)
59. T. Nakashima, Y. Kobayashi, S. Yamasaki, A. Kawakami, K. Eguchi, and H. Sasaki Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines Biochem Biophys Res Commun 275 2000 768 775
60. P. Brandtzaeg, L. Osnes, R. Ovstebo, G.B. Joo, A.B. Westvik, and P. Kierulf Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes J Exp Med 184 1996 51 60 (Pubitemid 26247214)
61. C.J. Clarke, A. Hales, A. Hunt, and B.M. Foxwell IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity Eur J Immunol 28 1998 1719 1726 (Pubitemid 28221177)
62. S. Hamlet, M. Alfarsi, R. George, and S. Ivanovski The effect of hydrophilic titanium surface modification on macrophage inflammatory cytokine gene expression Clin Oral Implants Res 23 2011 584 590
63. S. Akeel, A. El-Awady, K. Hussein, M. El-Refaey, M. Elsalanty, and M. Sharawy Recombinant bone morphogenetic protein-2 induces up-regulation of vascular endothelial growth factor and interleukin 6 in human pre-osteoblasts: role of reactive oxygen species Arch Oral Biol 57 2011 445 452
64. S.L. Hyzy, R. Olivares-Navarrete, Z. Schwartz, and B.D. Boyan BMP2 induces osteoblast apoptosis in a maturation state and noggin-dependent manner J Cell Biochem 113 2012 3236 3245
65. N. Fukuno, H. Matsui, Y. Kanda, O. Suzuki, K. Matsumoto, and K. Sasaki TGF-beta-activated kinase 1 mediates mechanical stress-induced IL-6 expression in osteoblasts Biochem Biophys Res Commun 408 2011 202 207
66. G. Courties, V. Seiffart, J. Presumey, V. Escriou, D. Scherman, and J. Zwerina In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells Blood 116 2010 3505 3516
67. M. Koide, Y. Murase, K. Yamato, T. Noguchi, N. Okahashi, and T. Nishihara Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2 Biochem Biophys Res Commun 259 1999 97 102 (Pubitemid 29264000)
68. E.D. Jensen, L. Pham, C.J. Billington Jr., K. Espe, A.E. Carlson, and J.J. Westendorf Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors J Cell Biochem 109 2010 672 682